125 related articles for article (PubMed ID: 16206589)
1. [Effect of infusion therapy on central hemodynamics and the outcome of treatment in patients with subarachnoidal hemorrhages].
Shatalov VI; Shchegolev AV
Anesteziol Reanimatol; 2005; (4):55-8. PubMed ID: 16206589
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic hyperdynamic postoperative fluid therapy after aneurysmal subarachnoid hemorrhage: a clinical, prospective, randomized, controlled study.
Egge A; Waterloo K; Sjøholm H; Solberg T; Ingebrigtsen T; Romner B
Neurosurgery; 2001 Sep; 49(3):593-605; discussion 605-6. PubMed ID: 11523669
[TBL] [Abstract][Full Text] [Related]
3. Does prophylactic postoperative hypervolemic therapy prevent cerebral vasospasm and improve clinical outcome after aneurysmal subarachnoid hemorrhage?
Capampangan DJ; Wellik KE; Aguilar MI; Demaerschalk BM; Wingerchuk DM
Neurologist; 2008 Nov; 14(6):395-8. PubMed ID: 19008746
[TBL] [Abstract][Full Text] [Related]
4. Effect of intraarterial papaverine or nimodipine on vessel diameter in patients with cerebral vasospasm after subarachnoid hemorrhage.
Kerz T; Boor S; Beyer C; Welschehold S; Schuessler A; Oertel J
Br J Neurosurg; 2012 Aug; 26(4):517-24. PubMed ID: 22303863
[TBL] [Abstract][Full Text] [Related]
5. Feasibility and safety of intrathecal nimodipine on posthaemorrhagic cerebral vasospasm refractory to medical and endovascular therapy.
Hänggi D; Beseoglu K; Turowski B; Steiger HJ
Clin Neurol Neurosurg; 2008 Sep; 110(8):784-90. PubMed ID: 18554777
[TBL] [Abstract][Full Text] [Related]
6. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study.
Schmid-Elsaesser R; Kunz M; Zausinger S; Prueckner S; Briegel J; Steiger HJ
Neurosurgery; 2006 Jun; 58(6):1054-65; discussion 1054-65. PubMed ID: 16723884
[TBL] [Abstract][Full Text] [Related]
7. Effect of Intra-Arterial and Intravenous Nimodipine Therapy of Cerebral Vasospasm After Subarachnoid Hemorrhage on Cerebrovascular Reactivity and Oxygenation.
Hockel K; Diedler J; Steiner J; Birkenhauer U; Ernemann U; Schuhmann MU
World Neurosurg; 2017 May; 101():372-378. PubMed ID: 28232152
[TBL] [Abstract][Full Text] [Related]
8. Continuous selective intra-arterial application of nimodipine in refractory cerebral vasospasm due to aneurysmal subarachnoid hemorrhage.
Ott S; Jedlicka S; Wolf S; Peter M; Pudenz C; Merker P; Schürer L; Lumenta CB
Biomed Res Int; 2014; 2014():970741. PubMed ID: 24527461
[TBL] [Abstract][Full Text] [Related]
9. Role of transcranial Doppler in optimizing treatment of cerebral vasospasm in subarachnoid hemorrhage.
Darwish RS; Ahn E; Amiridze NS
J Intensive Care Med; 2008; 23(4):263-7. PubMed ID: 18480082
[TBL] [Abstract][Full Text] [Related]
10. High-dose intra-arterial verapamil for the treatment of cerebral vasospasm after subarachnoid hemorrhage: prolonged effects on hemodynamic parameters and brain metabolism.
Stuart RM; Helbok R; Kurtz P; Schmidt M; Fernandez L; Lee K; Badjatia N; Mayer SA; Lavine S; Meyers P; Connolly ES; Claassen J
Neurosurgery; 2011 Feb; 68(2):337-45; discussion 345. PubMed ID: 21135735
[TBL] [Abstract][Full Text] [Related]
11. Intraarterial infusion of papaverine and change of cerebral hemodynamics in symptomatic cerebral vasospasm.
Minami H; Kuwamura K; Tamaki N
Kobe J Med Sci; 2001 Aug; 47(4):169-79. PubMed ID: 11733656
[TBL] [Abstract][Full Text] [Related]
12. Effects of the selective endothelin A (ET(A)) receptor antagonist Clazosentan on cerebral perfusion and cerebral oxygenation following severe subarachnoid hemorrhage - preliminary results from a randomized clinical series.
Barth M; Capelle HH; Münch E; Thomé C; Fiedler F; Schmiedek P; Vajkoczy P
Acta Neurochir (Wien); 2007; 149(9):911-8; discussion 918. PubMed ID: 17700991
[TBL] [Abstract][Full Text] [Related]
13. Haemodynamic augmentation in the treatment of vasospasm in aneurysmal subarachnoid hemorrhage.
Gura M; Elmaci I; Cerci A; Sagiroglu E; Coskun KK
Turk Neurosurg; 2012; 22(4):435-40. PubMed ID: 22843460
[TBL] [Abstract][Full Text] [Related]
14. [Systemic treatments of the vasospasm].
Tavernier B; Decamps F; Vega E; Poidevin P; Verdin M; Riegel B
Ann Fr Anesth Reanim; 2007 Nov; 26(11):980-4. PubMed ID: 17933488
[TBL] [Abstract][Full Text] [Related]
15. Evaluation function of transcranial two-dimensional and color Doppler ultrasonography (TCCS) for patients with different degrees of cerebral vasospasm before and after the nimodipine treatment.
Wang JL; Li XN; Zhang YH; Li X; Yang YL
Eur Rev Med Pharmacol Sci; 2017 Jun; 21(11):2757-2763. PubMed ID: 28678308
[TBL] [Abstract][Full Text] [Related]
16. The effect of intensive insulin therapy on infection rate, vasospasm, neurologic outcome, and mortality in neurointensive care unit after intracranial aneurysm clipping in patients with acute subarachnoid hemorrhage: a randomized prospective pilot trial.
Bilotta F; Spinelli A; Giovannini F; Doronzio A; Delfini R; Rosa G
J Neurosurg Anesthesiol; 2007 Jul; 19(3):156-60. PubMed ID: 17592345
[TBL] [Abstract][Full Text] [Related]
17. Detecting and treating microvascular ischemia after subarachnoid hemorrhage.
Sakowitz OW; Unterberg AW
Curr Opin Crit Care; 2006 Apr; 12(2):103-11. PubMed ID: 16543784
[TBL] [Abstract][Full Text] [Related]
18. Systemic administration of phosphodiesterase V inhibitor, sildenafil citrate, for attenuation of cerebral vasospasm after experimental subarachnoid hemorrhage.
Atalay B; Caner H; Cekinmez M; Ozen O; Celasun B; Altinors N
Neurosurgery; 2006 Nov; 59(5):1102-7; discussion 1107-8. PubMed ID: 17143244
[TBL] [Abstract][Full Text] [Related]
19. Intracisternal versus intracarotid infusion of L-arginine in experimental cerebral vasospasm.
Ozüm U; Aslan A; Karadağ O; Gürelik M; Taş A; Zafer Kars H
J Clin Neurosci; 2007 Jun; 14(6):556-62. PubMed ID: 17430779
[TBL] [Abstract][Full Text] [Related]
20. Endovascular therapy for vasospasm.
Srinivasan J; Eskridge J; Grady MS; Newell DW; Winn HR
Clin Neurosurg; 2002; 49():261-73. PubMed ID: 12506559
[No Abstract] [Full Text] [Related]
[Next] [New Search]
